Journal
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Volume 133, Issue 49, Pages 19598-19601Publisher
AMER CHEMICAL SOC
DOI: 10.1021/ja207607s
Keywords
-
Categories
Funding
- Scripps Research Institute
- National Institutes of Health (NIGMS) [1 R01 GM084019-02]
- Amgen
- Novartis
- Eli Lilly
- Bristol-Myers Squibb
- NSF GRFP
- NDSEG
- Skaggs-Oxford Scholarship Program
- Korean Government [NRF-2009-352-C00077]
- National Research Foundation of Korea [352-2009-1-C00077] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Ask authors/readers for more resources
Systematic ligand development has led to the identification of novel mono-N-protected amino acid ligands for Pd(II)-catalyzed enantioselective C-H activation of cyclopropanes. A diverse range of organoboron reagents can be used as coupling partners, and the reaction proceeds under mild conditions. These results provide a new retro-synthetic disconnection for the construction of enantioenriched cis-substituted cyclopropanecarboxylic acids.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
